Amino Acid Infusion in Kidney Transplant Recipients

ConditionsShort-term Graft Function Metabolic Effects Nutritional Effect Immunological &Amp; Inflammatory Markers Safety Adverse Events

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity Hospital, Martin

About this trial

The study addresses the impact of amino acid infusion in the early post-transplant period on graft function and the incidence of post-transplant complications.

Eligibility criteria

Qualifiers

Adult patients (≥18 years) undergoing deceased or living donor kidney transplantation

First-time kidney transplant recipients

No known allergy or contraindication to amino acids

Stable hemodynamic status post-transplant

Disqualifiers

Patients requiring immediate dialysis post-transplant

Multi-organ transplant recipients

Severe hepatic dysfunction (Child-Pugh C)

Uncontrolled infection or sepsis

Trial design

Treatments tested in this trial

Infusion Therapy
Saline solution infusion

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University Hospital, Martin

Lead sponsor

Source ClinicalTrials.gov